| Views | |
|---|---|
| risk-adapted use of vancomycin in secondary scoliosis surgery may normalize SSI risk in surgical correction of high-risk patients | 15 |
| January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | |
|---|---|---|---|---|---|---|---|
| risk-adapted use of vancomycin in secondary scoliosis surgery may normalize SSI risk in surgical correction of high-risk patients | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
| Views | |
|---|---|
| 2024_ Taheri_etal.pdf | 2 |
